Please login to the form below

Not currently logged in
Email:
Password:

Teva board elects Yitzhak Peterburg as chairman

He succeeds Phillip Frost
Yitzhak Peterburg

The Teva board has elected Yitzhak Peterburg as its chairman, succeeding Phillip Frost who is due to step down at the end of the year.

Peterburg has worked at Teva since 2009 and has been group VP head of global branded products for the firm since 2010.

His career also includes spells as CEO and president at telecoms company Cellcom Israel and CEO at Clalit Health Services, Israel's leading healthcare provider.

Frost, who was appointed chairman since, March 2010, has overseen an era of change for Teva as it looks to move beyond its generics background and build its specialty pharmaceuticals business.

Frost was said to have a strained relationship with Teva's former CEO Jeremy Levin who left the company in 2013 to be replaced by Erez Vigodman at the beginning of 2014.

Teva also appointed Sol Barer, the former chief executive of Celgene, as a director.

28th November 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics